Cargando…

Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro

BACKGROUND: Occurring frequently after solid organ and hematopoietic stem cell transplantation, cytomegalovirus (CMV) replication remains a relevant cause of mortality and morbidity in affected patients. Despite these adverse effects, an increased alloreactivity of natural killer (NK) cells after CM...

Descripción completa

Detalles Bibliográficos
Autores principales: Tschan-Plessl, Astrid, Stern, Martin, Schmied, Laurent, Retière, Christelle, Hirsch, Hans H., Garzoni, Christian, van Delden, Christian, Boggian, Katia, Mueller, Nicolas J., Berger, Christoph, Villard, Jean, Manuel, Oriol, Meylan, Pascal, Terszowski, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087575/
https://www.ncbi.nlm.nih.gov/pubmed/27830183
http://dx.doi.org/10.1097/TXD.0000000000000605
_version_ 1782463944658518016
author Tschan-Plessl, Astrid
Stern, Martin
Schmied, Laurent
Retière, Christelle
Hirsch, Hans H.
Garzoni, Christian
van Delden, Christian
Boggian, Katia
Mueller, Nicolas J.
Berger, Christoph
Villard, Jean
Manuel, Oriol
Meylan, Pascal
Terszowski, Grzegorz
author_facet Tschan-Plessl, Astrid
Stern, Martin
Schmied, Laurent
Retière, Christelle
Hirsch, Hans H.
Garzoni, Christian
van Delden, Christian
Boggian, Katia
Mueller, Nicolas J.
Berger, Christoph
Villard, Jean
Manuel, Oriol
Meylan, Pascal
Terszowski, Grzegorz
author_sort Tschan-Plessl, Astrid
collection PubMed
description BACKGROUND: Occurring frequently after solid organ and hematopoietic stem cell transplantation, cytomegalovirus (CMV) replication remains a relevant cause of mortality and morbidity in affected patients. Despite these adverse effects, an increased alloreactivity of natural killer (NK) cells after CMV infection has been assumed, but the underlying physiopathological mechanisms have remained elusive. METHODS: We used serial analyses of NK cells before and after CMV infection in kidney transplant recipients as an in vivo model for CMV primary infection to explore the imprint of CMV infection using every patient as their own control: We analyzed NK cell phenotype and function in 47 CMV seronegative recipients of CMV seropositive kidney grafts, who developed CMV primary infection posttransplant. Seronegative recipients of seronegative kidney grafts served as controls. RESULTS: We observed a significant increase of NKG2C expressing NK cells after CMV infection (mean increase, 17.5%; 95% confidence interval [95% CI], 10.2-24.9, P < 0.001), whereas cluster of differentiation (CD)57 expressing cells decreased (mean decrease, 14.1%; 95% CI, 8.0-20.2; P < 0.001). Analysis of killer immunoglobulin-like receptor (KIR) expression showed an increase of cells expressing KIR2DL1 as their only inhibitory KIR in patients carrying the cognate ligand HLA-C2 (mean increase, 10.0%; 95% CI, 1.7-18.3; P = 0.018). In C2-negative individuals, KIR2DL1 expression decreased (mean decrease, 3.9%; 95% CI, 1.6-6.2; P = 0.001). As for activating KIR, there was no conclusive change pattern. Most importantly, we observed a significantly higher NK cell degranulation and IFNγ production in response to different target cells (target K562, CD107a: mean increase, 9.9%; 95% CI, 4.8-15.0; P < 0.001; IFNγ: mean increase, 6.6%; 95% CI, 1.6-11.1; P < 0.001; target MRC-5, CD107a: mean increase, 6.9%; 95% CI, 0.7-13.1; P = 0.03; IFNγ: mean increase, 4.8%; 95% CI, 1.7-7.8; P = 0.002). CONCLUSIONS: We report evidence for an increased function of NK cells induced by CMV infection. This increased in vitro functionality was seen in NKG2C-positive and NKG2C-negative subsets, arguing for an NKG2C independent mechanism of action.
format Online
Article
Text
id pubmed-5087575
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-50875752017-03-27 Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro Tschan-Plessl, Astrid Stern, Martin Schmied, Laurent Retière, Christelle Hirsch, Hans H. Garzoni, Christian van Delden, Christian Boggian, Katia Mueller, Nicolas J. Berger, Christoph Villard, Jean Manuel, Oriol Meylan, Pascal Terszowski, Grzegorz Transplant Direct Kidney Transplantation BACKGROUND: Occurring frequently after solid organ and hematopoietic stem cell transplantation, cytomegalovirus (CMV) replication remains a relevant cause of mortality and morbidity in affected patients. Despite these adverse effects, an increased alloreactivity of natural killer (NK) cells after CMV infection has been assumed, but the underlying physiopathological mechanisms have remained elusive. METHODS: We used serial analyses of NK cells before and after CMV infection in kidney transplant recipients as an in vivo model for CMV primary infection to explore the imprint of CMV infection using every patient as their own control: We analyzed NK cell phenotype and function in 47 CMV seronegative recipients of CMV seropositive kidney grafts, who developed CMV primary infection posttransplant. Seronegative recipients of seronegative kidney grafts served as controls. RESULTS: We observed a significant increase of NKG2C expressing NK cells after CMV infection (mean increase, 17.5%; 95% confidence interval [95% CI], 10.2-24.9, P < 0.001), whereas cluster of differentiation (CD)57 expressing cells decreased (mean decrease, 14.1%; 95% CI, 8.0-20.2; P < 0.001). Analysis of killer immunoglobulin-like receptor (KIR) expression showed an increase of cells expressing KIR2DL1 as their only inhibitory KIR in patients carrying the cognate ligand HLA-C2 (mean increase, 10.0%; 95% CI, 1.7-18.3; P = 0.018). In C2-negative individuals, KIR2DL1 expression decreased (mean decrease, 3.9%; 95% CI, 1.6-6.2; P = 0.001). As for activating KIR, there was no conclusive change pattern. Most importantly, we observed a significantly higher NK cell degranulation and IFNγ production in response to different target cells (target K562, CD107a: mean increase, 9.9%; 95% CI, 4.8-15.0; P < 0.001; IFNγ: mean increase, 6.6%; 95% CI, 1.6-11.1; P < 0.001; target MRC-5, CD107a: mean increase, 6.9%; 95% CI, 0.7-13.1; P = 0.03; IFNγ: mean increase, 4.8%; 95% CI, 1.7-7.8; P = 0.002). CONCLUSIONS: We report evidence for an increased function of NK cells induced by CMV infection. This increased in vitro functionality was seen in NKG2C-positive and NKG2C-negative subsets, arguing for an NKG2C independent mechanism of action. Lippincott Williams & Wilkins 2016-06-17 /pmc/articles/PMC5087575/ /pubmed/27830183 http://dx.doi.org/10.1097/TXD.0000000000000605 Text en Copyright © 2016 The Authors. Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Kidney Transplantation
Tschan-Plessl, Astrid
Stern, Martin
Schmied, Laurent
Retière, Christelle
Hirsch, Hans H.
Garzoni, Christian
van Delden, Christian
Boggian, Katia
Mueller, Nicolas J.
Berger, Christoph
Villard, Jean
Manuel, Oriol
Meylan, Pascal
Terszowski, Grzegorz
Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
title Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
title_full Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
title_fullStr Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
title_full_unstemmed Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
title_short Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
title_sort human cytomegalovirus infection enhances nk cell activity in vitro
topic Kidney Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087575/
https://www.ncbi.nlm.nih.gov/pubmed/27830183
http://dx.doi.org/10.1097/TXD.0000000000000605
work_keys_str_mv AT tschanplesslastrid humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT sternmartin humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT schmiedlaurent humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT retierechristelle humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT hirschhansh humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT garzonichristian humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT vandeldenchristian humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT boggiankatia humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT muellernicolasj humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT bergerchristoph humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT villardjean humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT manueloriol humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT meylanpascal humancytomegalovirusinfectionenhancesnkcellactivityinvitro
AT terszowskigrzegorz humancytomegalovirusinfectionenhancesnkcellactivityinvitro